Phospholipids and Lipid-Based Formulations in Oral Drug Delivery

被引:0
|
作者
Gert Fricker
Torsten Kromp
Armin Wendel
Alfred Blume
Jürgen Zirkel
Herbert Rebmann
Constanze Setzer
Ralf-Olaf Quinkert
Frank Martin
Christel Müller-Goymann
机构
[1] Phospholipid Research Center,Institute of Pharmacy and Molecular Biotechnology
[2] Phospholipid GmbH,Institute of Chemistry
[3] Ruprecht-Karls-University,Institute of Pharmaceutical Technology
[4] Martin-Luther-University,undefined
[5] Lipoid GmbH Frigenstr. 4,undefined
[6] iMEDD Inc.,undefined
[7] Technical University,undefined
[8] Institute of Pharmacy and Molecular Biotechnology,undefined
来源
Pharmaceutical Research | 2010年 / 27卷
关键词
emulsion; liposome; phospholipid; self-emulsifying drug delivery systems; solid lipid nanoparticles;
D O I
暂无
中图分类号
学科分类号
摘要
Phospholipids become increasingly important as formulation excipients and as active ingredients per se. The present article summarizes particular features of commonly used phospholipids and their application spectrum within oral drug formulation and elucidates current strategies to improve bioavailability and disposition of orally administered drugs. Advantages of phospholipids formulations not only comprise enhanced bioavailability of drugs with low aqueous solubility or low membrane penetration potential, but also improvement or alteration of uptake and release of drugs, protection of sensitive active agents from degradation in the gastrointestinal tract, reduction of gastrointestinal side effects of non-steroidal anti-inflammatory drugs and even masking of bitter taste of orally applied drugs. Technological strategies to achieve these effects are highly diverse and offer various possibilities of liquid, semi-liquid and solid lipid-based formulations for drug delivery optimization.
引用
收藏
页码:1469 / 1486
页数:17
相关论文
共 50 条
  • [41] Supersaturated Lipid-Based Formulations to Enhance the Oral Bioavailability of Venetoclax
    Koehl, Niklas J.
    Henze, Laura J.
    Kuentz, Martin
    Holm, Rene
    Griffin, Brendan T.
    PHARMACEUTICS, 2020, 12 (06) : 1 - 20
  • [42] Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems
    Tanmoy Sadhukha
    Buddhadev Layek
    Swayam Prabha
    Drug Delivery and Translational Research, 2018, 8 : 375 - 386
  • [43] Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery
    Jennica L. Zaro
    The AAPS Journal, 2015, 17 : 83 - 92
  • [44] Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery
    Zaro, Jennica L.
    AAPS JOURNAL, 2015, 17 (01): : 83 - 92
  • [45] Tools for Early Prediction of Drug Loading in Lipid-Based Formulations
    Alskar, Linda C.
    Porter, Christopher J. H.
    Bergstrom, Christel A. S.
    MOLECULAR PHARMACEUTICS, 2016, 13 (01) : 251 - 261
  • [46] Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals
    Rajabalaya, Rajan
    Musa, Muhammad Nuh
    Kifli, Nurolaini
    David, Sheba R.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 393 - 406
  • [47] Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems
    Sadhukha, Tanmoy
    Layek, Buddhadev
    Prabha, Swayam
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2018, 8 (02) : 375 - 386
  • [48] A Lipid-Based System for the Oral Delivery of Growth Hormone
    Fricker, Gert
    Pantze, Silvia
    Parmentier, Johannes
    Helm, Frieder
    Hartmann, Klaus
    Gropp, Felix
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 365 - 365
  • [49] Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether
    Memvanga, Patrick B.
    Preat, Veronique
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 82 (01) : 112 - 119
  • [50] Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems
    Wasan, KM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (04) : 267 - 276